SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 3 filers reported holding SAREPTA THERAPEUTICS INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $31,541,444 | +122.8% | 260,200 | +110.5% | 5.74% | +107.3% |
| Q2 2023 | $14,154,672 | +49.6% | 123,600 | +69.3% | 2.77% | +49.5% |
| Q4 2022 | $9,459,340 | -34.9% | 73,000 | -62.4% | 1.85% | -46.8% |
| Q2 2022 | $14,535,000 | +11.0% | 193,900 | +33.4% | 3.49% | +19.8% |
| Q4 2021 | $13,094,000 | +15.5% | 145,405 | -41.8% | 2.91% | +31.9% |
| Q3 2017 | $11,340,000 | +148.9% | 250,000 | +4.6% | 2.21% | +69.0% |
| Q2 2016 | $4,556,000 | +55.6% | 238,900 | +59.3% | 1.30% | +24.2% |
| Q1 2016 | $2,928,000 | – | 150,000 | – | 1.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Perceptive Advisors | 2,878,979 | $69,182,000 | 7.27% |
| Eventide Asset Management | 259,100 | $6,226,000 | 0.97% |
| GLADE BROOK CAPITAL PARTNERS LLC | 251,000 | $6,032,000 | 0.93% |
| IMS Capital Management | 32,215 | $774,000 | 0.91% |
| Perceptive Advisors | 350,000 | $8,413,000 | 0.88% |
| Benchmark Capital Advisors | 34,900 | $839,000 | 0.58% |
| BECK CAPITAL MANAGEMENT, LLC | 24,744 | $636,000 | 0.49% |
| SABBY MANAGEMENT, LLC | 352,100 | $8,461,000 | 0.47% |
| Hatteras Alternative Mutual Funds, LLC | 39,404 | $947,000 | 0.46% |
| Potomac Capital Management, Inc. | 22,100 | $531,000 | 0.45% |